title: Psychosis in Parkinson's disease: how should we treat it?
authors.forename: Paul
authors.initials: P
authors.lastname: Shotbolt
authors.forename: Michael
authors.initials: M
authors.lastname: Samuel
authors.forename: David
authors.initials: D
authors.lastname: Anthony
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D011618:Psychotic Disorders / Q000209:etiology* / Q000628:therapy*
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents